Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-17

Clinical Trial Update: Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluated whether adding goserelin to radiation therapy improves outcomes in patients who have undergone surgery for recurrent or refr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zoladex (goserelin)

Snippet

Sponsor: UNICANCER | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED